Clinical Trial: A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230691) titled 'A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting' on Nov. 14.

Brief Summary: The purpose of this study is to describe the clinical and health-related outcomes of amivantamab-containing regimens for the treatment of advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC; most common type of lung cancer) in a real-world setting. Metastatic NSCLC is when this disease spreads to other parts of body. NSCLC may occur due to mutations (changes) in many genes including epidermal growth factor receptor (EGFR).

Study Start Da...